Not Medicare Enrolled

Dr. Rosa Gonzalez, M.D.

Child & Adolescent Psychiatry Physician · Beaumont, TX
Low-engagement
3560 DELAWARE ST STE 109, Beaumont, TX 77706
4098929347
In practice since 2012 (13 years)
NPI: 1306199385 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gonzalez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gonzalez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gonzalez

Dr. Rosa Gonzalez is a child & adolescent psychiatry physician in Beaumont, TX, with 13 years in practice.

Between the years covered by Open Payments, Dr. Gonzalez received a total of $7,344 from 27 pharmaceutical and/or device companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in child & adolescent psychiatry physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gonzalez is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice$ $7,344 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$7,344
Total received (2018-2024)
Avg $1,049/year across 7 years
Top 6% in TX for child & adolescent psychiatry physician
27
Companies
317
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,300 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$45 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,067
2023
$1,280
2022
$1,119
2021
$1,414
2020
$752
2019
$688
2018
$1,025

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sunovion Pharmaceuticals Inc.
$1,174
ITI, Inc.
$893
Takeda Pharmaceuticals U.S.A., Inc.
$700
Otsuka America Pharmaceutical, Inc.
$650
Tris Pharma Inc
$490
Supernus Pharmaceuticals, Inc.
$446
ABBVIE INC.
$405
Alkermes, Inc.
$339
Corium, LLC
$303
Ironshore Pharmaceuticals Inc.
$291
Lundbeck LLC
$267
Neurocrine Biosciences, Inc.
$219
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$168
Allergan, Inc.
$151
Corium, Inc.
$138
Teva Pharmaceuticals USA, Inc.
$107
Neos Therapeutics, LP
$90
AbbVie Inc.
$84
Adlon Therapeutics L.P.
$75
Shire North American Group Inc
$72
Allergan Inc.
$60
Vanda Pharmaceuticals Inc.
$55
Janssen Pharmaceuticals, Inc
$55
ARBOR PHARMACEUTICALS, INC.
$50
IRONSHORE PHARMACEUTICALS INC.
$35
Vertical Pharmaceuticals, LLC
$15
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 37.7% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · Dyanavel XR · Evekeo · FANAPT · Horizant · INGREZZA · INVEGA SUSTENNA · JORNAY PM · LATUDA · LYBALVI · METHYLPHENIDATE 72 · QELBREE · Qelbree · Quillivant · Quillivant XR · REXULTI · SPRAVATO · TRINTELLIX · Trintellix · UBRELVY · VRAYLAR · VYVANSE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for child & adolescent psychiatry physician in TX.

Looking for a child & adolescent psychiatry physician in Beaumont?
Compare child & adolescent psychiatry physicians in the Beaumont area by procedure volume, costs, and industry payment transparency.
Browse child & adolescent psychiatry physicians nearby

Geographic Context

Child & Adolescent Psychiatry Physicians within 10 mi
7
Per 100K population
2.8
County median income
$59,934
Nearest hospital
CHRISTUS SOUTHEAST TEXAS- ST ELIZABETH
2.5 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gonzalez is a child & adolescent psychiatry physician, and high industry engagement (low-engagement, top 6%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Gonzalez receive payments from pharmaceutical companies?
Yes. Dr. Gonzalez received a total of $7,344 from 27 companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Gonzalez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Child & Adolescent Psychiatry Physicians in Beaumont
Browse child & adolescent psychiatry physicians in Beaumont ranked by procedure volume and transparency data.
Highest volume
Top Child & Adolescent Psychiatry Physicians in TX
Child & Adolescent Psychiatry Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Child & Adolescent Psychiatry Physicians in TX
Which TX child & adolescent psychiatry physicians receive the most from drug and device companies.
By company
Sunovion Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Sunovion Pharmaceuticals Inc..
By company
ITI, Inc. Payments to Doctors
See all physicians who received payments from ITI, Inc..
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc..
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →